Intervention to reduce drug use and HIV incidence among high PrEP priority partnered YMSM
减少 PrEP 重点合作伙伴 YMSM 中吸毒和艾滋病毒发病率的干预措施
基本信息
- 批准号:10152563
- 负责人:
- 金额:$ 77.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-01 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAcquired Immunodeficiency SyndromeAddressAdherenceAgeAgreementAttentionBehavior TherapyBehavioralBiologicalBiological AssayBiological MarkersBloodCenters for Disease Control and Prevention (U.S.)CollectionCommunicationCouplesDataDevelopmentDoseDrug TargetingDrug usageEducationEpidemicFaceFundingFutureGenderGoalsHIVHIV InfectionsHIV SeronegativityHIV SeropositivityHIV riskHairHeterosexualsIncidenceIndividualInfectionInterventionIntervention StudiesInterviewJointsLinkLogisticsMeasuresMediatingModelingMotivationNatureParticipantPharmaceutical PreparationsPreventionPrevention strategyProviderPublic HealthRandomizedRecommendationReportingResearchResearch PersonnelRiskRisk BehaviorsRisk Reduction BehaviorSamplingSampling BiasesServicesSex BehaviorSexual HealthSpottingsStructure of nail of fingerTenofovirUnited StatesUnited States National Institutes of HealthVulnerable PopulationsWorkacceptability and feasibilityattentional controlbasecondomless anal sexcontrol trialcosteffectiveness implementation studyeffectiveness trialefficacy evaluationefficacy testingeligible participantexperiencefollow up assessmentgroup interventionhealth care settingsinnovationinterestintervention effectmenmen who have sex with menmotivational enhancement therapymultimodalitynovelpre-exposure prophylaxispreventprevention serviceprimary outcomepsychoeducationrecruitresponseservice interventionsexskillsskills trainingsubstance usetheoriestransmission processuptakeyoung manyoung men who have sex with men
项目摘要
Project Summary
CDC recommendations identify MSM in non-monogamous relationships and those in
relationships with an HIV positive partner as candidates for PrEP. Estimates suggest as many
as 79% of new HIV infections among young MSM (YMSM; ages 18-29) are transmitted between
main partners. Drug use is an established correlate of HIV transmission risk. For partnered men,
relational factors (e.g., sexual agreements) contextualize drug use and both drug use and
sexual agreements predict receptivity to PrEP. Together, these findings point to the need for
integrated intervention services – targeting drug use and sexual health –tailored for partnered
YMSM. Such services are essential to addressing the HIV epidemic in the US.
In response, our team has developed a 4-session MI-based intervention targeting PrEP
uptake/adherence, HIV TRB, and drug use among partnered YMSM. PARTNER (Prevention
And Risk: Treatment with a New Emphasis on Relationships) is delivered to individual YMSM in
relationships (not couples), which enhances the scalability of the proposed intervention. Our
preliminary pilot work has established the acceptability and feasibility of PARTNER. The primary
goal of the current study is to test the efficacy of PARTNER relative to an attention-matched
educational control condition used in previously funded NIH studies with HIV-negative YMSM.
We propose to recruit 240 HIV-negative partnered YMSM who report recent drug use and
sexual behavior consistent with CDC guidance for PrEP candidacy into a randomized control
trial. As part of a secondary aim, this project seeks to enhance the range of biological
measures for PrEP adherence currently available. The field standard for assessing tenofovir
metabolites is dried blood spot assay; however, fingernail assay has high acceptability and
lower cost. We propose to validate fingernail samples for PrEP adherence by correlating results
obtained from fingernail samples with dried blood spot data.
The study team is led by Dr. Tyrel J. Starks (PI), a new investigator with substantial experience
in the study of relationship factors associated with sexual health and MSM in relationships. He
has collaborated on numerous projects examining the nature of sexual agreements and their
association with substance use and HIV transmission risk behavior. He is supported by a study
team which includes Dr. Jeffrey Parsons, the PI of multiple intervention studies targeting sexual
health and substance use. He is also joined by Dr. Monica Gandhi, an expert in biological
assessment for PrEP adherence who has pioneered the use of novel matrices in previous NIH-
funded studies. The team brings extensive experience in behavioral intervention research,
relationship research, and biomedical assessment.
项目摘要
CDC建议在非一体性关系中确定MSM,以及
与艾滋病毒积极伴侣作为候选人的关系。估计表明很多
由于年轻MSM中79%的新艾滋病毒感染(YMSM; 18-29岁)是在之间传播的
主要合作伙伴。毒品使用是艾滋病毒传播风险的建立相关性。对于合伙人,
关系因素(例如,性协议)将吸毒和吸毒和使用的情况与
性协议可以预测准备的接受能力。这些发现一起表明需要
综合干预服务 - 针对毒品使用和性健康 - 旨在合作
YMSM。这种服务对于解决美国的艾滋病毒流行至关重要。
作为回应,我们的团队已经开发了针对PREP的4条基于MI的干预措施
合作YMSM的摄取/依从性,HIV TRB和药物使用。合作伙伴(预防
风险:以新的强调关系的治疗)已交付给单个YMSM
关系(不是夫妻),可以增强提出的干预措施的可扩展性。我们的
初步的试点工作已经确定了合作伙伴的可接受性和可行性。主要
本研究的目标是测试伴侣相对于注意力匹配的效率
在先前资助的NIH研究中,使用HIV阴性YMSM使用的教育控制条件。
我们建议招募240名HIV阴性合作的YMSM,他们报告了最近使用药物的使用和
性行为与CDC指南一致,以准备候选者进入随机对照
审判。作为次要目标的一部分,该项目旨在增强生物学的范围
目前可用的准备依从性措施。评估Tenofovir的现场标准
代谢产物是干斑测定的;但是,指甲分析具有很高的可接受性和
较低的成本。我们建议通过关联结果来验证指甲样品以依从性
从带有干血点数据的指甲样品中获得。
研究团队由具有丰富经验的新调查员Tyrel J. Starks(PI)领导
在研究与性健康和关系中的关系因素的研究中。他
已经合作研究了许多项目,以研究性协议的性质及其
与药物使用和HIV传播风险行为相关联。他得到了一项研究的支持
包括杰弗里·帕森斯博士(Jeffrey Parsons)的团队,针对性的多个干预研究的PI
健康和物质使用。他还加入了生物学专家Monica Gandhi博士
评估依从性的依从性,他在先前的NIH-中率先使用新物质
资助研究。该团队在行为干预研究中带来丰富的经验,
关系研究和生物医学评估。
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Psychosocial and Culturally-Specific Factors Related to Intimate Partner Violence Victimization among a Sample of Latino Sexual Minority Cis Men in the U.S.
- DOI:10.1177/08862605211072167
- 发表时间:2022-12
- 期刊:
- 影响因子:2.5
- 作者:Robles, Gabriel;Bosco, Stephen C.;Cardenas, Iris;Hostetter, Joletta;Starks, Tyrel J.
- 通讯作者:Starks, Tyrel J.
Keeps me awake at night: The potential of the COVID-19 pandemic to affect sleep quality among sexual minority men in the U.S.A.
- DOI:10.1037/sgd0000441
- 发表时间:2021-06
- 期刊:
- 影响因子:3.8
- 作者:Millar BM;Adebayo T;Dellucci TV;Behar E;Starks TJ
- 通讯作者:Starks TJ
Partners' Consensus About Joint Effort and COVID-19 Prevention Among Sexual Minority Men.
- DOI:10.1007/s10508-021-02063-z
- 发表时间:2022-01
- 期刊:
- 影响因子:3.8
- 作者:Starks TJ;Bosco SC;Doyle KM;Revenson TA
- 通讯作者:Revenson TA
Integrating intra-individual and dyadic factors in examining health among gay and bisexual men: A narrative review of recent literature.
- DOI:10.1080/1550428x.2019.1682740
- 发表时间:2020
- 期刊:
- 影响因子:3.4
- 作者:Robles G;Bosco SC;Dellucci TV;Starks TJ
- 通讯作者:Starks TJ
Intersecting Communities and PrEP Uptake among US-based Latinx Sexual Minority Men.
- DOI:10.1007/s40615-021-01154-w
- 发表时间:2022-12
- 期刊:
- 影响因子:3.9
- 作者:Robles, Gabriel;Hong, Chenglin;Yu, Melanie;Starks, Tyrel J
- 通讯作者:Starks, Tyrel J
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tyrel J Starks其他文献
Tyrel J Starks的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tyrel J Starks', 18)}}的其他基金
Couples Motivational Interviewing to reduce drug use and HIV risk in vulnerable male couples
夫妻动机访谈,以减少弱势男性夫妇的吸毒和艾滋病毒风险
- 批准号:
10757544 - 财政年份:2023
- 资助金额:
$ 77.84万 - 项目类别:
Expanding the potential of couples HIV testing: Adjunct modules to reduce drug use among vulnerable male couples
扩大夫妇艾滋病毒检测的潜力:减少弱势男性夫妇吸毒的辅助模块
- 批准号:
10403968 - 财政年份:2020
- 资助金额:
$ 77.84万 - 项目类别:
Evaluating the efficacy of annual CHTC retesting among male couples at high risk of HIV infection
评估 HIV 感染高危男性夫妇每年进行 CHTC 重新检测的效果
- 批准号:
10700394 - 财政年份:2020
- 资助金额:
$ 77.84万 - 项目类别:
Expanding the potential of couples HIV testing: Adjunct modules to reduce drug use among vulnerable male couples
扩大夫妇艾滋病毒检测的潜力:减少弱势男性夫妇吸毒的辅助模块
- 批准号:
10079536 - 财政年份:2020
- 资助金额:
$ 77.84万 - 项目类别:
Expanding the potential of couples HIV testing: Adjunct modules to reduce drug use among vulnerable male couples
扩大夫妇艾滋病毒检测的潜力:减少弱势男性夫妇吸毒的辅助模块
- 批准号:
10217086 - 财政年份:2020
- 资助金额:
$ 77.84万 - 项目类别:
Expanding the potential of couples HIV testing: Adjunct modules to reduce drug use among vulnerable male couples
扩大夫妇艾滋病毒检测的潜力:减少弱势男性夫妇吸毒的辅助模块
- 批准号:
10626930 - 财政年份:2020
- 资助金额:
$ 77.84万 - 项目类别:
Intervention to reduce drug use and HIV incidence among high PrEP priority partnered YMSM
减少 PrEP 重点合作伙伴 YMSM 中吸毒和艾滋病毒发病率的干预措施
- 批准号:
9926851 - 财政年份:2017
- 资助金额:
$ 77.84万 - 项目类别:
Intervention to reduce drug use and HIV incidence among high PrEP priority partnered YMSM
减少 PrEP 重点合作伙伴 YMSM 中吸毒和艾滋病毒发病率的干预措施
- 批准号:
9920804 - 财政年份:2017
- 资助金额:
$ 77.84万 - 项目类别:
Examining community-based effectiveness of a substance use and HIV risk reduction intervention for young men of color
检查基于社区的针对有色人种年轻男性的药物滥用和艾滋病毒风险降低干预措施的有效性
- 批准号:
9920523 - 财政年份:2016
- 资助金额:
$ 77.84万 - 项目类别:
相似海外基金
IAS 2023, the 12th IAS Conference on HIV Science, Brisbane, Australia, and virtually, 23-26 July 2023
IAS 2023,第 12 届 IAS HIV 科学会议,澳大利亚布里斯班,虚拟会议,2023 年 7 月 23-26 日
- 批准号:
10696505 - 财政年份:2023
- 资助金额:
$ 77.84万 - 项目类别:
Hermanos de Luna y Sol: A community-based HIV prevention intervention
Hermanos de Luna y Sol:基于社区的艾滋病毒预防干预措施
- 批准号:
10626689 - 财政年份:2023
- 资助金额:
$ 77.84万 - 项目类别: